18.07.2017 Views

Adalimumab Market

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

To assess the competition prevailing in the global market for<br />

adalimumab, the report profiles major players such as Pfizer,<br />

Amgen, Novartis AG, Boehringer Ingelheim GmbH, Mylan<br />

N.V., and AbbVie. At present, the most prominent player in the<br />

market is Abbott Laboratories. However, after the split of Abbott<br />

laboratories into two companies in 2013, Humira is now the<br />

product of AbbVie.<br />

About Us<br />

Transparency <strong>Market</strong> Research (TMR) is a global market<br />

intelligence company providing business information reports<br />

and services. The company’s exclusive blend of quantitative<br />

forecasting and trend analysis provides forward-looking insight<br />

for thousands of decision makers. TMR’s experienced team of<br />

analysts, researchers, and consultants use proprietary data<br />

sources and various tools and techniques to gather and analyze<br />

information.<br />

TMR’s data repository is continuously updated and revised by a<br />

team of research experts so that it always reflects the latest<br />

trends and information. With extensive research and analysis<br />

capabilities, Transparency <strong>Market</strong> Research employs rigorous<br />

primary and secondary research techniques to develop<br />

distinctive data sets and research material for business reports.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!